Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	3.87	6.96	20.48	18.7	31.54
Short-Term Investments	0	0	0.02	0.06	0.01
Cash & Cash Equivalents	3.87	6.96	20.5	18.76	31.55
Cash Growth	-44.45%	-66.05%	9.29%	-40.54%	-24.30%
Receivables	0.11	0.42	0.16	0.07	0.12
Other Current Assets	0.26	0.45	1.28	0.66	0.72
Total Current Assets	4.23	7.83	21.94	19.49	32.39
Property, Plant & Equipment	0.35	0.4	0.54	0.63	0.57
Long-Term Investments	0.05	0.05	0.06	0.06	0.07
Total Long-Term Assets	0.41	0.45	0.6	0.69	0.64
Total Assets	4.64	8.28	22.54	20.18	33.03
Accounts Payable	2.38	3	3.85	2.49	4.2
Deferred Revenue	0.32	0	0	0.09	0.33
Current Debt	0.27	0.29	0.29	0.31	0.37
Other Current Liabilities	-0.09	0	0	0.73	0.78
Total Current Liabilities	2.89	3.28	4.13	3.62	5.68
Long-Term Debt	0.07	0.09	0.19	0.26	0.18
Other Long-Term Liabilities	0.53	0	1.28	1.69	1.65
Total Long-Term Liabilities	0.6	0.09	1.48	1.95	1.82
Total Liabilities	3.5	3.37	5.61	5.57	7.5
Total Debt	0.34	0.37	0.48	0.57	0.55
Debt Growth	-7.72%	-22.59%	-15.05%	3.12%	-
Retained Earnings	-360.42	-349.86	-329.06	-313.71	-300.85
Shareholders' Equity	1.15	4.91	16.93	14.61	25.52
Net Cash / Debt	3.52	6.59	20.02	18.19	31
Net Cash / Debt Growth	-46.53%	-67.10%	10.04%	-41.32%	-25.62%
Working Capital	1.34	4.55	17.81	15.87	26.71
Book Value Per Share	1.83	15.56	76.19	65.69	115.60

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).